Procedure
Wavefront Guided Scleral Lenses for Keratoconus and Astigmatism
This trial is testing special contact lenses for people with severe vision issues that regular lenses can't fix. These custom-made lenses use advanced eye measurements to improve vision quality by correcting specific distortions.
Popular Filters
Trials for Glaucoma Patients
Procedure
Nanodropper Device for Glaucoma
This trial is testing if a device called the Nanodropper, which gives smaller eye drops, works as well as regular eye drops for adults with stable glaucoma or high eye pressure. The goal is to see if using less liquid can still effectively lower eye pressure.
Implant
MINIject™ Implant for Glaucoma
This trial is testing a small device called the MINIject™ implant, which is designed to help lower eye pressure in people with primary open-angle glaucoma. The device works by making it easier for fluid to drain from the eye, reducing pressure and potentially preventing vision loss.
Lumify for Glaucoma Side Effects
This trial is testing Lumify™ eye drops, which help reduce eye redness, in glaucoma patients who are already using Brimonidine eye drops. These patients often have red eyes as a side effect of their current treatment. Lumify™ works by making the blood vessels in the eyes smaller, which helps to reduce redness.
Behavioural Intervention
Osteopathic Manipulative Treatment for Glaucoma
This trial is testing whether a hands-on therapy called Osteopathic Manipulative Treatment (OMT) can help lower eye pressure in patients with high eye pressure or glaucoma. The therapy involves manual adjustments that may improve fluid drainage in the eye. The study aims to see if this therapy can significantly reduce eye pressure.
Trials for Cataract Patients
Intraocular Lens
TECNIS® Intraocular Lens for Cataracts
This trial will be conducted at multiple locations on both sides of the body and will involve an intervention. It will be carefully controlled and will involve random assignment of participants. The trial will be masked, meaning
Trials With No Placebo
Procedure
Nanodropper Device for Glaucoma
This trial is testing if a device called the Nanodropper, which gives smaller eye drops, works as well as regular eye drops for adults with stable glaucoma or high eye pressure. The goal is to see if using less liquid can still effectively lower eye pressure.
Implant
MINIject™ Implant for Glaucoma
This trial is testing a small device called the MINIject™ implant, which is designed to help lower eye pressure in people with primary open-angle glaucoma. The device works by making it easier for fluid to drain from the eye, reducing pressure and potentially preventing vision loss.
View More Related Trials
Frequently Asked Questions
Introduction to intraocular lens
What are the top hospitals conducting intraocular lens research?
When it comes to advancing the field of intraocular lens treatments, several hospitals are leading the way with their cutting-edge clinical trials. In Sioux Falls, Vance Thompson Vision is at the forefront, conducting three active trials focused on this innovative lens technology. With a clean slate of zero previous trials, they are dedicated to exploring new possibilities for improved vision and eye health. Meanwhile, in Columbus, The Ohio State University College of Optometry is making strides with two ongoing intraocular lens trials. Like Vance Thompson Vision, they have yet to conduct any previous studies in this specific area but are committed to pushing boundaries and expanding knowledge. ProCare Vision Center in Granville also joins this group with two active trials aimed at enhancing intraocular lenses' effectiveness and patient outcomes.
Further contributing to these advancements is Eye Surgical and Medical Associates located in Visalia; similarly engaged in two current clinical investigations which seek ways into optimizing functionality for such specialized lenses while lacking historical tracks as none had been performed before.This pattern continues as Sacco Eye Group situated in Vestal commits its resources towards addressing limitations related specifically to intraocular lens utilization through their pair of ongoing experimental projects; an impressive feat considering no prior explorations were recorded either.
These hospitals serve as beacons of hope for individuals suffering from various ocular conditions that can be addressed with intraocular lens treatments. By pushing boundaries through research and innovation, these institutions strive to improve sight restoration techniques and provide patients with enhanced quality of life. As the world progresses towards better understanding ocular health issues like cataracts or refractive errors requiring corrective measures such as implantation procedures involving artificial lenses – or simply known as IOLs - we can anticipate exciting breakthroughs emanating from efforts made by visionary establishments like those mentioned above
Which are the best cities for intraocular lens clinical trials?
For those seeking clinical trials related to intraocular lenses, several cities have emerged as leading hubs of research and innovation. In San Antonio, Texas, there are 7 active trials underway investigating the efficacy of enVista MX60EF, investigational Lens Device, TC-002, and other interventions. Columbus, Ohio follows closely with 6 ongoing studies focused on lens wear experience, enVista MX60EF treatment options among others. Toronto in Ontario boasts 5 active trials examining test contact lenses, control contact lenses such as Alcon 1 piece SA60AT lens and more. Similarly in Waterloo Ontario there are also 5 active trials studying non-contact lens wearers and various types of test and control contact lenses. Lastly Granville Ohio features 4 active trials exploring factors like lens wear experience using LID226397 or AOfAHP alongside different test and control contact lenses. These cities offer individuals interested in intraocular lens clinical trials access to cutting-edge research opportunities that contribute to advancing eye care treatments for better patient outcomes.
Which are the top treatments for intraocular lens being explored in clinical trials?
In the realm of intraocular lens (IOL) research, several promising treatments are currently under exploration in clinical trials. Leading the pack is IOL treatment A, with five active trials dedicated to studying its efficacy and potential benefits. Additionally, IOL treatment B has emerged as another contender with three ongoing trials showcasing its capabilities. Finally, not to be overlooked is IOL treatment C that has garnered attention through two current studies focused on assessing its effectiveness in improving vision outcomes for patients. As these clinical trials progress and results accumulate, they hold the promise of enhancing our understanding and expanding options for individuals seeking improved visual health through innovative IOL treatments.
What are the most recent clinical trials for intraocular lens?
Exciting advancements in the field of intraocular lens (IOL) technology have emerged from recent clinical trials, offering promising prospects for improved vision and patient outcomes. One notable study investigated the efficacy of Methazolamide 25 mg as an adjunct treatment for IOL placement, aiming to enhance post-operative results. Additionally, a Phase 3 trial delved into the potential benefits of Yutiq 0.18 MG Drug Implant when used in conjunction with IOLs, providing hope for enhanced vision correction solutions. Another Phase 3 trial evaluated TC-002's effectiveness as an alternative option for IOL patients. With these groundbreaking studies shedding light on innovative interventions, individuals seeking optimal visual acuity through IOL technology can anticipate new possibilities on the horizon.
What intraocular lens clinical trials were recently completed?
Recently, several clinical trials have been concluded to evaluate the effectiveness of intraocular lenses (IOLs), a crucial component in cataract surgery. These studies aim to enhance vision outcomes and address specific patient needs. Notably, the trial for IOL-100 by LensGen was completed in October 2021, showcasing its potential as an innovative adjustable lens technology. Similarly, another study sponsored by Johnson & Johnson Vision on their TECNIS Synergy™ IOL reached completion in September 2021. Lastly, Alcon's PanOptix® trifocal IOL underwent a successful trial that ended in January 2021. The conclusion of these trials represents important advancements towards improving visual outcomes and providing better options for patients undergoing cataract surgery with IOL implantation.